[{"id":"f2c492b8-d008-47fb-bfe0-8880113c29ed","acronym":"","url":"https://clinicaltrials.gov/study/NCT06113289","created_at":"2023-11-02T15:12:40.366Z","updated_at":"2025-02-25T15:21:01.496Z","phase":"Phase 1/2","brief_title":"A Phase 1B/2A Trial of Combination of ASTX727 with ASTX029 in Acute Myeloid Leukemia","source_id_and_acronym":"NCT06113289","lead_sponsor":"M.D. Anderson Cancer Center","biomarkers":" KRAS • NF1 • PTPN11","pipe":"","alterations":" ","tags":["KRAS • NF1 • PTPN11"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Inqovi (decitabine/cedazuridine) • beroterkib anhydrous (ASTX029)"],"overall_status":"Suspended","enrollment":" Enrollment 42","initiation":"Initiation: 02/08/2024","start_date":" 02/08/2024","primary_txt":" Primary completion: 05/01/2027","primary_completion_date":" 05/01/2027","study_txt":" Completion: 05/01/2029","study_completion_date":" 05/01/2029","last_update_posted":"2025-02-12"}]